CompletedPhase 3NCT00928798
Topical Rapamycin for Fibrofolliculomas
Studying Birt-Hogg-Dubé syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Maastricht University Medical Center
- Principal Investigator
- Maurice van Steensel, Dr.Department of Dermatology
- Intervention
- Rapamycin(drug)
- Enrollment
- 19 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2010 – 2011
Study locations (2)
- VU Medical Centre Amsterdam, Amsterdam, Netherlands
- Maastricht University Medical Centre, Maastricht, Netherlands
Collaborators
Myrovlytis Trust
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00928798 on ClinicalTrials.govOther trials for Birt-Hogg-Dubé syndrome
Additional recruiting or active studies for the same condition.